Our results demonstrated that the expression of PD-L1 was upregulated and the expression rate of TIGIT was high after cCRT relative to that after drug therapy, and the patients with NSCLC after cCRT with high expression of both PD-L1 and TIGIT had a significantly poor prognosis. This evidence concerns the gene CD274 and non-small cell lung carcinoma.